Page last updated: 2024-09-02

exp3174 and dihydropyridines

exp3174 has been researched along with dihydropyridines in 1 studies

Compound Research Comparison

Studies (exp3174)	Trials (exp3174)	Recent Studies (post-2010) (exp3174)	Studies (dihydropyridines)	Trials (dihydropyridines)	Recent Studies (post-2010) (dihydropyridines)
236	29	43	5,022	529	969

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iouzalen, L; Marche, P; Stepien, O	1

Other Studies

1 other study(ies) available for exp3174 and dihydropyridines

Article	Year
Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles	1999

Article

Year

Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.

The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1

Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles

1999